Precigen, Inc. (PGEN)
7.10
-0.04
(-0.56%)
USD |
NASDAQ |
Sep 04, 16:00
7.11
+0.01
(+0.14%)
After-Hours: 20:00
Precigen Cash from Investing (Quarterly) : 26.69M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 26.69M |
| March 31, 2026 | 20.97M |
| December 31, 2025 | 39.87M |
| September 30, 2025 | -63.39M |
| June 30, 2025 | 28.44M |
| March 31, 2025 | -6.457M |
| December 31, 2024 | -65.37M |
| September 30, 2024 | 5.653M |
| June 30, 2024 | 14.96M |
| March 31, 2024 | 24.04M |
| December 31, 2023 | 13.29M |
| September 30, 2023 | 10.52M |
| June 30, 2023 | 23.50M |
| March 31, 2023 | -50.41M |
| December 31, 2022 | 11.42M |
| September 30, 2022 | 181.86M |
| June 30, 2022 | 16.57M |
| March 31, 2022 | 16.57M |
| December 31, 2021 | 15.93M |
| September 30, 2021 | 22.01M |
| June 30, 2021 | 16.62M |
| March 31, 2021 | -129.10M |
| December 31, 2020 | 40.18M |
| September 30, 2020 | 0.181M |
| June 30, 2020 | 23.97M |
| Date | Value |
|---|---|
| March 31, 2020 | -36.55M |
| December 31, 2019 | 54.51M |
| September 30, 2019 | 13.78M |
| June 30, 2019 | -15.03M |
| March 31, 2019 | 33.59M |
| December 31, 2018 | 30.74M |
| September 30, 2018 | -161.03M |
| June 30, 2018 | -13.46M |
| March 31, 2018 | -7.456M |
| December 31, 2017 | 23.91M |
| September 30, 2017 | 28.14M |
| June 30, 2017 | 17.73M |
| March 31, 2017 | 33.64M |
| December 31, 2016 | 16.75M |
| September 30, 2016 | -63.77M |
| June 30, 2016 | 14.74M |
| March 31, 2016 | 3.88M |
| December 31, 2015 | -3.493M |
| September 30, 2015 | -239.51M |
| June 30, 2015 | 8.225M |
| March 31, 2015 | -26.03M |
| December 31, 2014 | 10.46M |
| September 30, 2014 | -39.75M |
| June 30, 2014 | -22.60M |
| March 31, 2014 | 25.86M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | -1.28M |
| Geron Corp. | 8.295M |
| Neurocrine Biosciences, Inc. | -135.40M |
| Aldeyra Therapeutics, Inc. | -0.0231M |
| Elicio Therapeutics, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -17.81M |
| Cash from Financing (Quarterly) | -0.033M |
| Free Cash Flow | -115.22M |
| Free Cash Flow Per Share (Quarterly) | -0.044 |
| Free Cash Flow to Equity (Quarterly) | -18.30M |
| Free Cash Flow to Firm (Quarterly) | -15.25M |
| Free Cash Flow Yield | -4.54% |